|
||||||||||||||||||
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe NIB42 antibody reacts with human interferon-gamma (IFN-γ). The NIB42 antibody is a neutralizing antibody. IFN-γ is an ~20 kDa factor produced by activated T, B and NK cells and is an anti-viral and anti-parasitic cytokine. IFN-γ in synergy with other cytokines, such as TNF-α, inhibits proliferation of normal and transformed cells. Immunomodulatory effects of IFN-γ are exerted on a wide range of cell types expressing the high affinity receptors for IFN-γ. Glycosylation of IFN-γ does not affect its biological activity. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The NIB42 antibody has been reported for use in neutralization of human IFN-γ and for ELISA capture. Applications TestedThe Functional Grade Purified NIB42 antibody has been tested by LAL assay to verify low endotoxin levels and has been tested for ELISA capture and in bioassay for neutralization of IFN-γ bioactivity. The NIB42 antibody at 5 ug/ml has been found to inhibit by 50% the biological effects of 1 ng/ml human IFN-γ(ND50), in an EMCV assay of A549 cell protection. Detailed information and protocols about cytokine bioassays and in vitro cytokine neutralization using antibodies can be found in the BestProtocols section. The NIB42 antibody has been tested as the capture antibody in a sandwich ELISA for analysis of human Interferon-gamma (IFN-g) in combination with the biotin 4S.B3 (13-7319) antibody for detection and recombinant human IFNg (39-8319) as the standard. A suitable range of concentrations of this antibody for ELISA capture is 2-8 µg/ml. A standard curve consisting of doubling dilutions of the recombinant standard over the range of 1000 pg/ml - 8 pg/ml should be included in each ELISA plate. For ELISPOT capture, the alternative clone MD-1 is recommended. References
Meager, A., S. Parti, et al. (1984). "Detection of hybridomas secreting monoclonal antibodies to human gamma interferon using a rapid screening technique and specificity of certain monoclonal antibodies to gamma interferon." J Interferon Res 4(4): 619-25. Related ProductsCat. 88-7234 Mouse IL-23 (p19/p40, IL23) ELISA Ready-SET-Go! Cat. 16-7317 Functional Grade Purified anti-human IFNg (Interferon-gamma, IFN-g) (clone MD-1) Cat. 13-7319 Biotin anti-human IFNg (Interferon-gamma, IFN-g) (clone 4S.B3) Cat. 34-8049 Carrier-Free Recombinant Human IL-4 (Interleukin-4, IL4) Cat. 14-8129 Recombinant Human IL-12 (Interleukin-12, IL12) p70 Cat. 14-8239 Recombinant Human IL-23 (Interleukin-23, IL23) Cat. 34-8239 Carrier-Free Recombinant Human IL-23 (Interleukin-23, IL23) |
|||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2009 eBioscience, Inc. For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent. |